AKBA: Akebia Therapeutics Inc
AKBA exchange rate has changed by 1.49% for today. During the day, the instrument was traded at a low of 1.34 and at a high of 1.41.
Follow Akebia Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
AKBA News
- Akebia Post-Selloff: Revenue Dynamics And Upcoming Catalysts (NASDAQ:AKBA)
- Akebia reports first patient dosed in rare kidney disease trial
- Akebia Therapeutics begins phase 2 trial for rare kidney disease drug
- Oppenheimer maintains Outperform rating on Q32 Bio stock at $20 target
- Lee Kalowski, Q32 Bio CFO, sells $31k in shares
- Q32 Bio CEO Morrison sells $77870 in stock
- Akebia Therapeutics stock rating reiterated at Buy by H.C. Wainwright
- Q32 Bio stock rockets after selling Phase 2 complement inhibitor to Akebia
- Why Is Small-Cap Q32 Bio Stock Soaring On Monday? - Akebia Therapeutics (NASDAQ:AKBA), Q32 Bio (NASDAQ:QTTB)
- Implied Volatility Surging for Akebia Therapeutics Stock Options
- Theravance's Q3 Earnings Surpass Estimates, Revenues Match
- Akebia Therapeutics (AKBA) Loses 39.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- Akebia Therapeutics, Inc. (AKBA) Q3 2025 Earnings Call Transcript
- Mettler-Toledo Q3 Earnings Top Estimates, Sales Decline Y/Y
- Globus Medical (GMED) Tops Q3 Earnings and Revenue Estimates
- Zevra Therapeutics (ZVRA) Reports Q3 Loss, Lags Revenue Estimates
- Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November - Acadia Healthcare Co (NASDAQ:ACHC), Akebia Therapeutics (NASDAQ:AKBA)
- InvestingPro’s overvalued call on Akebia proved right as stock tumbled 44%
- Caterpillar, Fiserv Lead Market Cap Stock Movers on Wednesday
- Akebia Therapeutics: Dialysis-Only Path Puts VOCAL/Protocol Wins At The Core (NASDAQ:AKBA)
- Caterpillar, Nvidia Lead Market Cap Stock Movers on Wednesday
- Why Is Akebia Therapeutics Stock Plunging Today - Akebia Therapeutics (NASDAQ:AKBA)
Frequently Asked Questions
What is AKBA stock price today?
Akebia Therapeutics Inc stock is priced at 1.36 today. It trades within 1.34 - 1.41, yesterday's close was 1.34, and trading volume reached 2761. The live price chart of AKBA shows these updates.
Does Akebia Therapeutics Inc stock pay dividends?
Akebia Therapeutics Inc is currently valued at 1.36. Dividend policy depends on the company, while investors also watch -36.74% and USD. View the chart live to track AKBA movements.
How to buy AKBA stock?
You can buy Akebia Therapeutics Inc shares at the current price of 1.36. Orders are usually placed near 1.36 or 1.66, while 2761 and 1.49% show market activity. Follow AKBA updates on the live chart today.
How to invest into AKBA stock?
Investing in Akebia Therapeutics Inc involves considering the yearly range 1.31 - 4.08 and current price 1.36. Many compare -16.05% and -62.74% before placing orders at 1.36 or 1.66. Explore the AKBA price chart live with daily changes.
What are Akebia Therapeutics Inc stock highest prices?
The highest price of Akebia Therapeutics Inc in the past year was 4.08. Within 1.31 - 4.08, the stock fluctuated notably, and comparing with 1.34 helps spot resistance levels. Track Akebia Therapeutics Inc performance using the live chart.
What are Akebia Therapeutics Inc stock lowest prices?
The lowest price of Akebia Therapeutics Inc (AKBA) over the year was 1.31. Comparing it with the current 1.36 and 1.31 - 4.08 shows potential long-term entry points. Watch AKBA moves on the chart live for more details.
When did AKBA stock split?
Akebia Therapeutics Inc has gone through stock splits historically. These changes are visible in , 1.34, and -36.74% after corporate actions.
- Previous Close
- 1.34
- Open
- 1.34
- Bid
- 1.36
- Ask
- 1.66
- Low
- 1.34
- High
- 1.41
- Volume
- 2.761 K
- Daily Change
- 1.49%
- Month Change
- -16.05%
- 6 Months Change
- -62.74%
- Year Change
- -36.74%
- Act
- Fcst
- Prev